Login
$TCI
$49.30 +$0.90 (1.86%) Close

Consolidated balance sheets

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Assets
Real estate
Cash and cash equivalents
Restricted cash
Short-term investments
Notes receivable (including $55,032 and $57,468 at June 30, 2026 and December 31, 2025, respectively, from related parties)
Investment in unconsolidated joint venture
Receivables from related party
Other assets (including $1,030 and $1,259 at June 30, 2026 and December 31, 2025, respectively, from related parties)
Total assets
Liabilities and Equity
Liabilities:
Mortgages and other notes payable
Bonds payable
Accounts payable and other liabilities (including $31 and $30 at June 30, 2026 and December 31, 2025, respectively, to related parties)
Accrued interest
Deferred revenue
Total liabilities
Equity
Common stock, $0.01 par value, 10,000,000 shares authorized; 8,639,316 shares issued and outstanding
Additional paid-in capital
Retained earnings
Total shareholders' equity
Noncontrolling interest
Total equity
Total liabilities and equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support